TABLE 4.
Synergistic interactions of natural compounds in combination with antibiotics against RGM strainsa
| Antibiotics | |||||||
|---|---|---|---|---|---|---|---|
| Natural | AMI | CLA | LZD | ||||
| Compounds | Strain | FICI | Interpretation | FICI | Interpretation | FICI | Interpretation |
| tCIN | MAB1 | 0.50 | SY | 0.63 | AD | 0.38 | SY |
| MAB4 | 0.38 | SY | 0.75 | AD | 0.52 | AD | |
| MAB5 | 0.38 | AD | 0.28 | SY | 0.50 | SY | |
| MC4 | 0.53 | AD | 0.28 | SY | 0.38 | SY | |
| MC6 | 1.00 | AD | 1.00 | AD | 0.53 | AD | |
| MC7 | 0.75 | AD | 0.75 | AD | 0.63 | AD | |
| MF1 | 0.38 | SY | 0.63 | AD | 1.25 | IN | |
| MF3 | 0.25 | SY | 0.25 | SY | 2.03 | IN | |
| MF6 | 0.38 | SY | 0.38 | SY | 2.06 | IN | |
| ATCC14468 | 0.53 | AD | 0.27 | SY | 0.25 | SY | |
| CAR | MAB1 | 2.06 | AD | 0.38 | SY | 0.19 | SY |
| MAB4 | 0.38 | SY | 0.75 | AD | 0.53 | AD | |
| MAB5 | 0.38 | SY | 0.50 | SY | 0.27 | SY | |
| MC4 | 0.75 | AD | 0.63 | AD | 0.50 | SY | |
| MC6 | 1.00 | AD | 0.63 | AD | 0.38 | SY | |
| MC7 | 0.75 | AD | 0.75 | AD | 0.56 | AD | |
| MF1 | 0.50 | SY | 4.01 | IN | 1.00 | AD | |
| MF3 | 0.28 | SY | 1.02 | AD | 0.19 | SY | |
| MF6 | 0.50 | SY | 1.50 | IN | 0.50 | SY | |
| ATCC14468 | 0.50 | SY | 0.31 | SY | 0.25 | SY | |
| GEN | MAB1 | 1.03 | AD | 0.38 | SY | 1.25 | IN |
| MAB4 | 0.53 | AD | 0.53 | AD | 1.25 | IN | |
| MAB5 | 1.03 | AD | 0.38 | SY | 1.25 | IN | |
| MC4 | 0.63 | AD | 0.31 | SY | 1.03 | AD | |
| MC6 | 0.56 | AD | 0.53 | AD | 0.38 | SY | |
| MC7 | 0.56 | AD | 0.56 | AD | 0.56 | AD | |
| MF1 | 0.56 | AD | 0.52 | AD | 1.03 | AD | |
| MF3 | 0.53 | AD | 0.38 | SY | 0.75 | AD | |
| MF6 | 0.53 | AD | 0.50 | SY | 0.75 | AD | |
| ATCC14468 | 0.75 | AD | 0.27 | SY | 0.75 | AD | |
| PHL | MAB1 | 1.02 | AD | 0.63 | AD | 1.00 | AD |
| MAB4 | 1.02 | AD | 0.52 | AD | 1.00 | AD | |
| MAB5 | 1.02 | AD | 0.38 | SY | 1.00 | AD | |
| MC4 | 1.02 | AD | 0.56 | AD | 0.75 | AD | |
| MC6 | 1.03 | AD | 2.03 | IN | 0.38 | SY | |
| MC7 | 1.13 | IN | 0.53 | AD | 0.50 | SY | |
| MF1 | 0.52 | AD | 0.51 | AD | 1.00 | AD | |
| MF3 | 0.52 | AD | 0.56 | AD | 1.00 | AD | |
| MF6 | 0.52 | AD | 0.56 | AD | 0.63 | AD | |
| ATCC14468 | 1.25 | IN | 0.75 | AD | 1.50 | IN | |
| CIT | MAB1 | 0.50 | SY | 0.31 | SY | 0.63 | AD |
| MAB4 | 0.50 | SY | 0.38 | SY | 0.50 | SY | |
| MAB5 | 0.38 | SY | 0.25 | SY | 0.38 | SY | |
| MC4 | 0.57 | AD | 0.53 | AD | 1.27 | IN | |
| MC6 | 0.38 | SY | 0.50 | SY | 1.00 | AD | |
| MC7 | 0.19 | SY | 0.25 | SY | 0.32 | SY | |
| MF1 | 0.08 | SY | 0.56 | AD | 0.50 | SY | |
| MF3 | 0.28 | SY | 0.38 | SY | 0.33 | SY | |
| MF6 | 0.13 | SY | 0.25 | SY | 0.38 | SY | |
| ATCC14468 | 0.16 | SY | 0.38 | SY | 0.75 | AD | |
| GER | MAB1 | 0.50 | SY | 0.13 | SY | 0.19 | SY |
| MAB4 | 0.19 | SY | 0.19 | SY | 0.19 | SY | |
| MAB5 | 0.25 | SY | 0.31 | SY | 0.25 | SY | |
| MC4 | 0.39 | SY | 1.02 | IN | 0.63 | AD | |
| MC6 | 0.56 | AD | 2.00 | IN | 1.13 | IN | |
| MC7 | 0.19 | SY | 0.16 | SY | 0.19 | SY | |
| MF1 | 0.19 | SY | 0.25 | SY | 0.75 | AD | |
| MF3 | 0.19 | SY | 0.13 | SY | 0.13 | SY | |
| MF6 | 0.13 | SY | 0.16 | SY | 0.16 | SY | |
| ATCC14468 | 0.13 | SY | 0.09 | SY | 0.63 | AD | |
Determined using the checkerboard assays. Fractional inhibitory concentration Indexes (FICIs) were interpreted as synergistic (SY) when it was ≦0.5, as additive (AD) when it was >0.5–1, indifferent (IN) when it was >1–4.0, and antagonistic (AN) when it was >4 (Phytomedicine. 2015). tCIN, trans-Cinnamaldehyde; CAR, carvacrol; GEN, gentisaldehyde; PHL, phloroglucinaldehyde; CIT, citral; GER, geraniol; AMI, amikacin; CLA, clarithromycin; LZD, linezolid.